{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11(17)"],"submitter":["Cagnin S"],"funding":["EFSD/Sanofi research grant and CNR Progetto EBRI/Accordo MIUR"],"pubmed_abstract":["Diabetes leads to cardiomyopathy and heart failure, the leading cause of death for diabetic patients. Monoamine oxidase (MAO) inhibition in diabetic cardiomyopathy prevents oxidative stress, mitochondrial and endoplasmic reticulum stress and the development of diastolic dysfunction. However, it is unclear whether, in addition to the direct effects exerted on the mitochondria, MAO activity is able to post-transcriptionally regulate cardiomyocyte function and survival in diabetes. To this aim, we performed gene and miRNA expression profiling in cardiac tissue from streptozotocin-treated mice (model of type 1 diabetes (T1D)), administered with either vehicle or MAOs inhibitor pargyline for 12 weeks. We found that inhibition of MAO activity in T1D hearts leads to profound transcriptomic change"],"journal":["Cells"],"pagination":["2697"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9454570"],"repository":["biostudies-literature"],"pubmed_title":["Monoamine Oxidase-Dependent Pro-Survival Signaling in Diabetic Hearts Is Mediated by miRNAs."],"pmcid":["PMC9454570"],"pubmed_authors":["Cagnin S","Pacchioni B","Kaludercic N","Troiano C","Millino C","Brugnaro M","Di Sante M"],"additional_accession":[]},"is_claimable":false,"name":"Monoamine Oxidase-Dependent Pro-Survival Signaling in Diabetic Hearts Is Mediated by miRNAs.","description":"Diabetes leads to cardiomyopathy and heart failure, the leading cause of death for diabetic patients. Monoamine oxidase (MAO) inhibition in diabetic cardiomyopathy prevents oxidative stress, mitochondrial and endoplasmic reticulum stress and the development of diastolic dysfunction. However, it is unclear whether, in addition to the direct effects exerted on the mitochondria, MAO activity is able to post-transcriptionally regulate cardiomyocyte function and survival in diabetes. To this aim, we performed gene and miRNA expression profiling in cardiac tissue from streptozotocin-treated mice (model of type 1 diabetes (T1D)), administered with either vehicle or MAOs inhibitor pargyline for 12 weeks. We found that inhibition of MAO activity in T1D hearts leads to profound transcriptomic change","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Aug","modification":"2026-06-20T03:24:01.486Z","creation":"2025-02-19T04:38:30.358Z"},"accession":"S-EPMC9454570","cross_references":{"pubmed":["36078109"],"doi":["10.3390/cells11172697"]}}